Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2004 | 2005 | 2006 | 2007 | |
|---|---|---|---|---|
| Revenue | $835.1K | $966.5K | $1.2M | $2.8M |
| Cost of revenue | $0 | $449.5K | $434.6K | $2.7M |
| Gross profit | $835.1K | $517.0K | $742.0K | $144.0K |
| Gross margin | 100.0% | 53.5% | 63.1% | 5.1% |
| R&D | $0 | $0 | $0 | $3.1M |
| Operating income | $835.1K | $35.9K | $144.0K | $12.3M |
| EBITDA | $835.1K | −$28.6K | $157.6K | −$16.5M |
| Net income | −$34.3K | −$35.9K | $94.0K | −$17.2M |
| Net margin | -4.1% | -3.7% | 8.0% | -610.5% |
| EPS (diluted) | 0.00 | -0.00 | 0.01 | -0.27 |
Annual figures · source: Financial Modeling Prep
RXELITE INC
No one on the platform currently holds RXEI.
No tracked institution reports a position in RXEI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2007-07-17 | 11.036789-for-1 |
No one on the platform has traded RXEI yet.
| -90.00% |
| $1313 |
| — |
| INTPIntegrated Pharmaceuticals, Inc. | $0.00 | +0.00% | $1787 | — |
| MLTOMEDirect Latino, Inc. | $0.00 | +0.00% | $1700 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.